Cristina Banella
Florence, 50139, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Metabolic Signature of FLT3-Mutated AML: Clinical and Therapeutic Implications.
Journal: Journal of personalized medicine
Published: June 26, 2025
PML::RARα+ myeloid cells display metabolic alterations that can be targeted to treat resistant/relapse acute promyelocytic leukemias.
Journal: Leukemia
Published: March 21, 2025
Characterization of a novel IDH2-R159H mutation in acute myeloid leukaemia: Effects on cell metabolism and differentiation.
Journal: British journal of haematology
Published: September 19, 2023
MCL1 regulates AML cells metabolism via direct interaction with HK2. Metabolic signature at onset predicts overall survival in AMLs' patients.
Journal: Leukemia
Published: December 28, 2022
Ascorbate Plus Buformin in AML: A Metabolic Targeted Treatment.
Journal: Cancers
Published: April 26, 2022
CD99 as a novel therapeutic target on leukemic progenitor cells in FLT3-ITDmut AML.
Journal: Leukemia
Published: January 10, 2022
NPM1 Mutated, BCR-ABL1 Positive Myeloid Neoplasms: Review of the Literature.
Journal: Mediterranean journal of hematology and infectious diseases
Published: August 26, 2020
Genetic lesions disrupting calreticulin 3'-untranslated region in JAK2 mutation-negative polycythemia vera.
Journal: American journal of hematology
Published: June 10, 2020
PML/RARa Interferes with NRF2 Transcriptional Activity Increasing the Sensitivity to Ascorbate of Acute Promyelocytic Leukemia Cells.
Journal: Cancers
Published: December 20, 2019
Absence of FGFR3-TACC3 rearrangement in hematological malignancies with numerical chromosomal alteration.
Journal: Hematology/oncology and stem cell therapy
Published: December 10, 2019
Last Updated: 09/26/2026